Passive constraint and new shape-change devices for heart failure

Seminars in Thoracic and Cardiovascular Surgery

Volumn 14, Issue 2, 2002, Pages 150-156

  Kaplon, Richard ^a   Lombardi, Pierluca ^a  

^a Mercy General Hospital   (United States)

Author keywords

Acorn; Heart failure; Myosplint

Indexed keywords

POLYESTER;

ARTICLE; CONTROLLED STUDY; HEART ASSIST DEVICE; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE REMODELING; HEART VENTRICLE SIZE; HUMAN;

EID: 0036096817     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/stcs.2002.32316     Document Type: Article

References (35)

1. Effect of carvedilol on survival in severe chronic heart failure
2. Myocardial revascularization as a therapeutic strategy in the patient with advanced ventricular dysfunction
3. Mitral valve repair in heart failure
4. Mitral valve surgery for patients with severe left ventricular dysfunction
5. Long-term use of a left ventricular assist device for end-stage heart failure
6. 2001 Heart and stroke statistical update
7. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease
8. Early results with partial left ventriculectomy
9. Partial left ventriculectomy for dilated cardiomyopathy: Is this an alternative to transplantation?
10. Effects of latissimus dorsi dynamic cardiomyoplasty on ventricular function
11. Girdling effect of nonstimulated cardiomyoplasty on left ventricular function
12. Reverse remodeling from cardiomyoplasty in human heart failure
13. Stabilization of chronic remodeling by asynchronous cardiomyoplasty in dilated cardiomyopathy. Effects of a conditioned muscle wrap
14. Passive ventricular constraint for the treatment of congestive heart failure
15. Passive containment and reverse remodeling by a novel textile cardiac support device
16. Ventricular containment as an adjunctive procedure in ischemic cardiomyopathy: Early results
17. Passive ventricular constraint is a trigger for a significant degree of reverse remodeling in an experimental model of degenerative heart failure and dilated cardiomyopathy
18. Passive ventricular constraint amends the course of heart failure: A study in an ovine model of dilated cardiomyopathy
19. Passive epicardial containment prevents ventricular remodeling in heart failure
20. Prevention of progressive left ventricular dilation with the Acorn Cardiac Support Device downregulates stretch-mediated p21ras, attenuates myocyte hypertrophy and improves sarcoplasmic reticulum calcium cycling failure
21. Prevention of progressive left ventricular dilation with the Acorn Cardiac Support Device normalizes protein phosphatase activity in dogs with chronic heart failure
22. Chronic therapy with the Acorn Cardiac Support Device attenuates cardiomyocyte apoptosis in dogs with heart failure
23. Chronic therapy with the Acorn Cardiac Support Device in dogs with chronic heart failure: Three and six months hemodynamic, histologic and ultrastructural findings
24. Efficacy trends with the Acorn Cardiac Support Device: One year follow-up
25. Novel device to change to left ventricular shape for heart failure treatment: Device design and implantation procedure
26. Device based left ventricular shape change immediately reduces left ventricular volume and increases ejection fraction in a pacing induced cardiomyopathy model in dogs: A pilot study
27. Device-based change in left ventricular shape: A new concept for the treatment of dilated cardiomyopathy
28. Device based left ventricular shape change as a new surgical therapy for heart failure: A pilot study in a pacing induced canine cardiomyopathy model
29. An alternative to left ventricular volume reduction
30. Left ventricular shape change reduced left ventricular wall stress in patients with dilated cardiomyopathy
31. Myosplint implantation and ventricular shape change in patients with dilative cardiomyopathy - First clinical experience
32. Effect of captopril on progressive ventricular dilatation after anterior wall myocardial infarction
33. Healing the heart with ventricular assist device therapy: Mechanisms of cardiac recovery
34. Prevention of dilatation using the Acorn CSD results in reversed remodeling and improvement of function
35. New heart failure therapy: The shape of things to come?